Results 91 to 100 of about 37,594 (237)

A Retrospective Study on the Impact of Primary Aldosteronism in Pregnancy (H.A.P.P.I. Study Group)

Clinical Endocrinology, Volume 104, Issue 2, Page 113-122, February 2026.
ABSTRACT Objective Primary aldosteronism (PA) is a common cause of hypertension in young women. However, there is a paucity of data regarding its impact during pregnancy. The primary objective of this study was to describe the occurrence of hypertensive disorders of pregnancy (HDP) in PA.
Diana Oprea, Frédérique Lefrançois, Matthieu St‐Jean, Anne‐Marie Côté, Marie‐Ève Roy‐Lacroix, Mandy Malick, Pierre‐Luc Mallet, Nadine Sauvé   +7 more
wiley   +1 more source

Nifedipine-induced Hyperglycaemia in an Infant: A Case Report

Nigerian Journal of Paediatrics
Summary: This case report describes reversible hyperglycaemia in a severely ill six-month old Saudi boy treated with nifedipine for hypertension. Hyperglycaemia became manifest on the second day of treatment with nifedipine and was not dose-related ...
Jobran Al Qhtani , Abdulla A Al Harthi , Yousef Katinni , Ahmed Al Barki , Sulaiman Al-Fifi , Asindi A Asindi , Saad Al Daama   +6 more
doaj  

Dipipanone and nifedipine in cold induced pain; analgesia not due to skin warming. [PDF]

, 1987
RL Holland, N. Harkin, S. R. Coleshaw, DA Jones, AW Peck, András Telekes   +5 more
openalex   +1 more source

Evaluation of a 3D‐Printed Model as Complete Case Scenario in Undergraduate Dental Education—Diagnosis, Treatment Planning and Clinical Practice

European Journal of Dental Education, Volume 30, Issue 1, Page 133-147, February 2026.
ABSTRACT Introduction 3D‐printed teeth/models are important adjuncts in dental education. Nevertheless, there is a lack of simulated cases to learn and understand complex treatment scenarios, including anamnesis, diagnosis, treatment planning and therapy.
Sebastian Bürklein, Edgar Schäfer, David Donnermeyer   +2 more
wiley   +1 more source

E007 Lacidipine and nifedipine gits as fixed-dose monopharmacotherapies in essential hypertension over sixteen weeks: Main results of the lastlhy [PDF]

, 1998
Ariel J. Reyes
openalex   +1 more source

Rethinking Strategies for a Pharmaceutical Approach to Pain Related to Connective Tissue–Related Raynaud Phenomenon in the United States

Arthritis Care &Research, Volume 78, Issue 1, Page 106-112, January 2026.
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech, Charles G. Frech, W. David Merryman, Andrew Sternlicht, Justin Baba   +4 more
wiley   +1 more source

The pharmacokinetical aspects of nifedipine in pregnant women with placental insufficiency in the phone preeclampsia

RUDN Journal of Medicine, 2010
In 55 cases of nifedipine usage it's pharmacokinetics and placenta permeability index (PPI) at 25 women of the main group were studied. Pharmacokinetical parameters showed that nifedipine usage at non-severe forms of preeclampsia with placental ...
F B Buranova
doaj  

Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy. [PDF]

, 1986
Piergiuseppe Agostoni, Nicoletta De Cesare, E Doria, A Polese, Gloria Tamborini, Marco Guazzi   +5 more
openalex   +1 more source

Morphine Tolerance Gated through EZH2‐Mediated Suppression of Trpc5 in Spinal GABAergic Interneurons in Male Mice

Advanced Science, Volume 13, Issue 1, 5 January 2026.
Chronic morphine suppresses Trpc5 in spinal GABAergic interneurons via EZH2‐mediated histone modification, reducing Ca2+ influx and GABA release. TRPC5 activation enhances morphine analgesia, while EZH2 inhibition restores efficacy and reverses tolerance.
Li Wan, Mengyao Zhang, Haiyue Guo, Yan Xu, Chenjie Xu, Fan Hu, Yinbing Pan, Xian Wang, Wentao Liu, Chun‐Yi Jiang   +9 more
wiley   +1 more source

Combination of folic acid with nifedipine is completely effective in attenuating aortic aneurysm formation as a novel oral medication

, 2022
Kai Huang, Yusi Wu, Yixuan Zhang, Ji Youn Youn, Hua Cai   +4 more
openalex   +1 more source